EUCALIA Inc.
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
EUCALIA Inc. owes ¥0.67 for every ¥1 it owns. Net profit rose 37% in the year to Dec 2025, and grew 41% a year on average over 3 years.
Compared with Healthcare companies in Japan · latest annual results Dec 2025.
P/E ratio
10.9Investors pay ¥10.9 for every ¥1 of EUCALIA Inc.'s yearly profit, lower than 81% of Healthcare companies in Japan.
P/B ratio
1.25The share price is 1.25 times EUCALIA Inc.'s book value per share, lower than 63% of Healthcare companies in Japan.
Market cap
¥26.3 BThe total market value of all of EUCALIA Inc.'s shares at today's price (share price × number of shares), larger than 55% of Healthcare companies in Japan. PosiCap size class: Mini Cap.
Net worth (book value)
¥21.0 BWhat EUCALIA Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
¥588.34Net worth divided by the number of shares. The share price of ¥737.00 is 1.3 times this, which is the P/B above.
Return on equity (ROE)
12.1%EUCALIA Inc. earned 12.1% on its shareholders' money over the last year, higher than 75% of Healthcare companies in Japan.
Owes vs Owns
0.67×EUCALIA Inc. owes ¥0.67 for every ¥1 it owns (moderate), higher than 81% of Healthcare companies in Japan.
Dividend yield
NoneEUCALIA Inc. does not currently pay a dividend.
Revenue growth
+25%Revenue rose 25% in the year to Dec 2025, and grew 14% a year on average over 3 years.
Profit growth
+37%Net profit rose 37% in the year to Dec 2025, and grew 41% a year on average over 3 years.
Profit margin
11.2%EUCALIA Inc. keeps ¥11 of every ¥100 of revenue as net profit.
Cash quality
-0.7×Cash from EUCALIA Inc.'s business was -0.7× its reported profit in the year to Dec 2025 — the business used cash even though it reported a profit.
Interest cover
7.0×EUCALIA Inc.'s operating profit covered its interest costs 7.0 times in the year to Dec 2025.
Cash vs debt
Net debtEUCALIA Inc. had ¥15.9 B more debt than cash (net debt) at Dec 2025.
Questions
What is EUCALIA Inc.'s P/E ratio?
Investors pay ¥10.9 for every ¥1 of EUCALIA Inc.'s yearly profit, lower than 81% of Healthcare companies in Japan.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For EUCALIA Inc.: ¥26.3 B ÷ ¥21.0 B (30 Jun 2026) = 1.3.
What is EUCALIA Inc.'s return on equity?
EUCALIA Inc. earned 12.1% on its shareholders' money over the last year, higher than 75% of Healthcare companies in Japan.
How much does EUCALIA Inc. owe compared with what it owns?
EUCALIA Inc. owes ¥0.67 for every ¥1 it owns (moderate), higher than 81% of Healthcare companies in Japan.
Does EUCALIA Inc. pay a dividend?
No. EUCALIA Inc. does not currently pay a dividend.
Is EUCALIA Inc.'s revenue growing?
Revenue rose 25% in the year to Dec 2025, and grew 14% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.